Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Efficacy of Antiscorpion Venom Serum(AScVS)vs Prazosin in the Management of Severe Scorpion(Mesobuthus Tamulus Concanesis Pocock)Envenomation and Evaluation of Effects of the Combination of AScVS + Prazosin Therapy.

NCT00753064 is registered in ClinicalTrials.gov with Haffkine Bio-Pharmaceutical Corporation Ltd. as lead sponsor.

NCT NCT00753064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00753064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Efficacy of Antiscorpion Venom Serum(AScVS)vs Prazosin in the Management of Severe Scorpion(Mesobuthus Tamulus Concanesis Pocock)Envenomation and Evaluation of Effects of the Combination of AScVS + Prazosin Therapy.
Lead sponsor
Haffkine Bio-Pharmaceutical Corporation Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
December 31, 2007
Enrollment
81 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

scorpion envenomation